Brind.

Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.

1 report, 1 independent Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Pfizer, Novartis, Merck, and Intravacc are competing in the high-cost gene therapy market, utilizing specialized manufacturing and vaccine production services.Sub-event
  2. Pfizer and Novartis are notable market players in epilepsy therapeutics.Sub-event
  3. Market growth is being driven by advanced therapies involving Pfizer, Novartis, and Merck.Sub-event
  4. Cytokinetics and Pfizer announced strong US sales growth for Camzyos and a co-development agreement for Eliquis.Sub-event
  5. Market growth in advanced therapies driven by Pfizer, Novartis, and Merck.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireChronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma Th